The U.S. economic burden of chronic diseases such as Alzheimer’s, diabetes, heart disease, obesity and cancer has reached about $3.8 trillion in direct and indirect costs—or nearly one-fifth of GDP, according to a new report from
Fitch Solutions, which is a unit of Fitch Group.
And as the baby boomer population ages alongside a concurrent increase in the prevalence of noncommunicable diseases, that figure is expected to double within the next 30 years, Fitch reports.
“This considerable...